Non-PVC IV Bags Market Report by Material (Ethylene Vinyl Acetate, Copolyester-ether, Polypropylene, and Others), Product (Multi Chamber, Single Chamber), Content (Frozen Mixture, Liquid Mixture), Application (Chemotherapy, Targeted Drug Delivery, Glucose Injection, Sodium Chloride Solution, Electrolyte Injection, Nutrient Injection, and Others), End User (Hospitals, Clinics, Emergency Service Centers, Ambulatory Surgical Centers, and Others), and Region 2024-2032
The global non-PVC IV bags market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2032, exhibiting a growth rate (CAGR) of 6.1% during 2024-2032.
Non-polyvinyl chloride (non-PVC) intravenous (IV) bags are manufactured using polypropylene, polyethylene, copolyester-ether, and ethylene-vinyl acetate films. They are specifically designed for packaging rehydration solutions and storing certain antibiotics and analgesics for hospital and veterinary usage. Moreover, they can be extensively utilized in cold storage without inhibiting the quality and shelf-life of the stored items. Unlike PVC IV bags that often face drug and container interaction problems, these bags provide improved safety, lowered risks of contamination and enhanced convenience of usage. As a result, non-PVC IV bags find extensive applications in parenteral nutrition, oncology, chemotherapy, and targeted drug deliveries.
Non-PVC IV Bags Market Trends:
The market is primarily driven by the rising incidences of hospital-acquired infections (HAIs) among the masses. Coupled with the increasing influx of patients requiring intravenous antibiotics across healthcare facilities, this has provided a boost to the uptake of non-PVC IV bags. Also, the widespread adoption of single-chambered non-PVC IV bags in IV drips and other mixtures due to their convenience of management, transportation, and disposal is significantly contributing to the product sales. In addition to this, the growing number of point-of-care (POC) facilities across the globe and the preference for home care setups, especially for the geriatric population, are favorably impacting the market growth. The market is further driven by the escalating popularity of IV bags made up of ethylene-vinyl acetate (EVA). Since these bags offer excellent adhesion to non-porous substrates at an affordable price point, they are widely utilized by healthcare professionals on the global level. Some of the other factors creating a positive outlook for the market include the augmenting demand for biologically inert medical supplies, considerable developments in the healthcare infrastructure and extensive research and development (R&D) activities.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global non-PVC IV bags market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on material, product, content, application and end user.
Breakup by Material:
Ethylene Vinyl Acetate
Copolyester-ether
Polypropylene
Others
Breakup by Product:
Multi Chamber
Single Chamber
Breakup by Content:
Frozen Mixture
Liquid Mixture
Breakup by Application:
Chemotherapy
Targeted Drug Delivery
Glucose Injection
Sodium Chloride Solution
Electrolyte Injection
Nutrient Injection
Others
Breakup by End User:
Hospitals
Clinics
Emergency Service Centers
Ambulatory Surgical Centers
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Fresenius SE & Co. KGaA, JW Life Science Co. Ltd., Kraton Corporation (DL Chemical Co. Ltd.), Medline Industries LP, Persico S.p.a., Sealed Air Corporation and Sippex IV bags.
Key Questions Answered in This Report
1. What was the size of the global non-PVC IV bags market in 2023?
2. What is the expected growth rate of the global non-PVC IV bags market during 2024-2032?
3. What are the key factors driving the global non-PVC IV bags market?
4. What has been the impact of COVID-19 on the global non-PVC IV bags market?
5. What is the breakup of the global non-PVC IV bags market based on the material?
6. What is the breakup of the global non-PVC IV bags market based on the product?
7. What is the breakup of the global non-PVC IV bags market based on content?
8. What is the breakup of the global non-PVC IV bags market based on the end user?
9. What are the key regions in the global non-PVC IV bags market?
10. Who are the key players/companies in the global non-PVC IV bags market?
Non-polyvinyl chloride (non-PVC) intravenous (IV) bags are manufactured using polypropylene, polyethylene, copolyester-ether, and ethylene-vinyl acetate films. They are specifically designed for packaging rehydration solutions and storing certain antibiotics and analgesics for hospital and veterinary usage. Moreover, they can be extensively utilized in cold storage without inhibiting the quality and shelf-life of the stored items. Unlike PVC IV bags that often face drug and container interaction problems, these bags provide improved safety, lowered risks of contamination and enhanced convenience of usage. As a result, non-PVC IV bags find extensive applications in parenteral nutrition, oncology, chemotherapy, and targeted drug deliveries.
Non-PVC IV Bags Market Trends:
The market is primarily driven by the rising incidences of hospital-acquired infections (HAIs) among the masses. Coupled with the increasing influx of patients requiring intravenous antibiotics across healthcare facilities, this has provided a boost to the uptake of non-PVC IV bags. Also, the widespread adoption of single-chambered non-PVC IV bags in IV drips and other mixtures due to their convenience of management, transportation, and disposal is significantly contributing to the product sales. In addition to this, the growing number of point-of-care (POC) facilities across the globe and the preference for home care setups, especially for the geriatric population, are favorably impacting the market growth. The market is further driven by the escalating popularity of IV bags made up of ethylene-vinyl acetate (EVA). Since these bags offer excellent adhesion to non-porous substrates at an affordable price point, they are widely utilized by healthcare professionals on the global level. Some of the other factors creating a positive outlook for the market include the augmenting demand for biologically inert medical supplies, considerable developments in the healthcare infrastructure and extensive research and development (R&D) activities.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global non-PVC IV bags market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on material, product, content, application and end user.
Breakup by Material:
Ethylene Vinyl Acetate
Copolyester-ether
Polypropylene
Others
Breakup by Product:
Multi Chamber
Single Chamber
Breakup by Content:
Frozen Mixture
Liquid Mixture
Breakup by Application:
Chemotherapy
Targeted Drug Delivery
Glucose Injection
Sodium Chloride Solution
Electrolyte Injection
Nutrient Injection
Others
Breakup by End User:
Hospitals
Clinics
Emergency Service Centers
Ambulatory Surgical Centers
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Fresenius SE & Co. KGaA, JW Life Science Co. Ltd., Kraton Corporation (DL Chemical Co. Ltd.), Medline Industries LP, Persico S.p.a., Sealed Air Corporation and Sippex IV bags.
Key Questions Answered in This Report
1. What was the size of the global non-PVC IV bags market in 2023?
2. What is the expected growth rate of the global non-PVC IV bags market during 2024-2032?
3. What are the key factors driving the global non-PVC IV bags market?
4. What has been the impact of COVID-19 on the global non-PVC IV bags market?
5. What is the breakup of the global non-PVC IV bags market based on the material?
6. What is the breakup of the global non-PVC IV bags market based on the product?
7. What is the breakup of the global non-PVC IV bags market based on content?
8. What is the breakup of the global non-PVC IV bags market based on the end user?
9. What are the key regions in the global non-PVC IV bags market?
10. Who are the key players/companies in the global non-PVC IV bags market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL NON-PVC IV BAGS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY MATERIAL
6.1 Ethylene Vinyl Acetate
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Copolyester-ether
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Polypropylene
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY PRODUCT
7.1 Multi Chamber
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Single Chamber
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY CONTENT
8.1 Frozen Mixture
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Liquid Mixture
8.2.1 Market Trends
8.2.2 Market Forecast
9 MARKET BREAKUP BY APPLICATION
9.1 Chemotherapy
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Targeted Drug Delivery
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Glucose Injection
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Sodium Chloride Solution
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Electrolyte Injection
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 Nutrient Injection
9.6.1 Market Trends
9.6.2 Market Forecast
9.7 Others
9.7.1 Market Trends
9.7.2 Market Forecast
10 MARKET BREAKUP BY END USER
10.1 Hospitals
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Clinics
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Emergency Service Centers
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Ambulatory Surgical Centers
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 MARKET BREAKUP BY REGION
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT ANALYSIS
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 VALUE CHAIN ANALYSIS
14 PORTERS FIVE FORCES ANALYSIS
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 PRICE ANALYSIS
16 COMPETITIVE LANDSCAPE
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 B. Braun Melsungen AG
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 SWOT Analysis
16.3.2 Baxter International Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Becton Dickinson and Company
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 Fresenius SE & Co. KGaA
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 JW Life Science Co. Ltd.
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.6 Kraton Corporation (DL Chemical Co. Ltd.)
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.7 Medline Industries LP
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 SWOT Analysis
16.3.8 Persico S.p.a.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.9 Sealed Air Corporation
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Sippex IV bags
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL NON-PVC IV BAGS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY MATERIAL
6.1 Ethylene Vinyl Acetate
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Copolyester-ether
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Polypropylene
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY PRODUCT
7.1 Multi Chamber
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Single Chamber
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY CONTENT
8.1 Frozen Mixture
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Liquid Mixture
8.2.1 Market Trends
8.2.2 Market Forecast
9 MARKET BREAKUP BY APPLICATION
9.1 Chemotherapy
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Targeted Drug Delivery
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Glucose Injection
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Sodium Chloride Solution
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Electrolyte Injection
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 Nutrient Injection
9.6.1 Market Trends
9.6.2 Market Forecast
9.7 Others
9.7.1 Market Trends
9.7.2 Market Forecast
10 MARKET BREAKUP BY END USER
10.1 Hospitals
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Clinics
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Emergency Service Centers
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Ambulatory Surgical Centers
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 MARKET BREAKUP BY REGION
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT ANALYSIS
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 VALUE CHAIN ANALYSIS
14 PORTERS FIVE FORCES ANALYSIS
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 PRICE ANALYSIS
16 COMPETITIVE LANDSCAPE
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 B. Braun Melsungen AG
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 SWOT Analysis
16.3.2 Baxter International Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Becton Dickinson and Company
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 Fresenius SE & Co. KGaA
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 JW Life Science Co. Ltd.
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.6 Kraton Corporation (DL Chemical Co. Ltd.)
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.7 Medline Industries LP
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 SWOT Analysis
16.3.8 Persico S.p.a.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.9 Sealed Air Corporation
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Sippex IV bags
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
